First Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide, Work Together in Healthy People, in People With High Body Weight and in People With Diabetes

NCT04259801 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

152

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Overweight
Obesity
Diabetes Mellitus, Type 2

Interventions

DRUG: NNC0480-0389
DRUG: Semaglutide
DRUG: Placebo (NNC0480-0389)
DRUG: Placebo (semaglutide)

Sponsor

Novo Nordisk A/S